Connection

Thomas Uhde to Methoxyhydroxyphenylglycol

This is a "connection" page, showing publications Thomas Uhde has written about Methoxyhydroxyphenylglycol.
Connection Strength

0.501
  1. The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder. J Psychiatr Res. 1998 Jan-Feb; 32(1):11-7.
    View in: PubMed
    Score: 0.149
  2. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls. Psychoneuroendocrinology. 1990; 15(3):217-24.
    View in: PubMed
    Score: 0.085
  3. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry. 1988 Mar 15; 23(6):575-85.
    View in: PubMed
    Score: 0.075
  4. Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmacol Bull. 1984; 20(3):426-30.
    View in: PubMed
    Score: 0.056
  5. The relationship of plasma free MHPG to anxiety and psycho-physical pain in normal volunteers. Psychopharmacol Bull. 1982 Oct; 18(4):129-32.
    View in: PubMed
    Score: 0.052
  6. Hypothalamic-pituitary-adrenocortical activity in panic disorder: relationship to plasma catecholamine metabolites. Biol Psychiatry. 1991 Sep 01; 30(5):502-6.
    View in: PubMed
    Score: 0.024
  7. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry. 1984 Feb; 19(2):131-56.
    View in: PubMed
    Score: 0.014
  8. Biological peripheral correlates of anxiety. Encephale. 1982; 8(2):119-30.
    View in: PubMed
    Score: 0.012
  9. Indices of noradrenergic output in depression. Psychiatry Res. 1986 Sep; 19(1):59-73.
    View in: PubMed
    Score: 0.004
  10. Plasma HVA and anxiety in patients with panic disorder. Biol Psychiatry. 1986 Jul; 21(8-9):849-53.
    View in: PubMed
    Score: 0.004
  11. Biological alterations in the primary affective disorders and other tricyclic-responsive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(1):15-24.
    View in: PubMed
    Score: 0.004
  12. Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients. Psychopharmacology (Berl). 1985; 87(1):59-63.
    View in: PubMed
    Score: 0.004
  13. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. Am J Psychiatry. 1984 Jun; 141(6):733-41.
    View in: PubMed
    Score: 0.004
  14. Plasma cortisol responses to clonidine in depressed patients and controls. Evidence for a possible alteration in noradrenergic-neuroendocrine relationships. Arch Gen Psychiatry. 1984 Jan; 41(1):63-8.
    View in: PubMed
    Score: 0.004
  15. Growth hormone response to clonidine in obsessive-compulsive patients. Br J Psychiatry. 1983 Feb; 142:184-7.
    View in: PubMed
    Score: 0.003
  16. Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):249-61.
    View in: PubMed
    Score: 0.003
  17. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res. 1982 Apr; 6(2):171-83.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.